Biological Triggers of Depression in Pregnancy

ClinicalTrials.gov ID: NCT02566980

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02566980. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 13, 2026, 2:42 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The Role of Kynurenine Pathway Metabolites in Perinatal Depression and Suicidality

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The goal of the study is to define and measure biological processes that contribute to the underlying pathophysiologic process of peri-partum depression to be used for identifying those at risk for developing it. This knowledge may also generate novel drug targets for peripartum depression that may be applicable to other types of depression.

Study identification

NCT ID: NCT02566980
Recruitment status: Completed
Study type: Observational
Phase: Not listed
Lead sponsor: Michigan State University; Other
Enrollment: 209 participants

Conditions and interventions

Conditions

Interventions

Not listed

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 23, 2014 (Actual)
Primary completion: Feb 28, 2017 (Actual)
Completion: Feb 28, 2017 (Actual)
Last update posted: Jun 28, 2018

2014 – 2017

United States locations

U.S. sites: 3
U.S. states: 1
U.S. cities: 1

Facility	City	State	ZIP	Site status
Spectrum Health System	Grand Rapids	Michigan	49503	—
Van Andel Research Institute	Grand Rapids	Michigan	49503	—
Pine Rest Christian Mental Health Services	Grand Rapids	Michigan	49548	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02566980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 28, 2018 · Synced Nov 13, 2026